SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-19-000027
Filing Date
2019-05-10
Accepted
2019-05-09 19:34:45
Documents
94
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20190331x10q.htm 10-Q 2238212
2 EX-10.1 amph-20190331ex101a6c27b.htm EX-10.1 970785
3 EX-10.2 amph-20190331ex1026e4135.htm EX-10.2 71992
4 EX-31.1 amph-20190331ex31133f923.htm EX-31.1 22850
5 EX-31.2 amph-20190331ex31238da58.htm EX-31.2 22976
6 EX-32.1 amph-20190331ex32115f56c.htm EX-32.1 12328
7 EX-32.2 amph-20190331ex322099558.htm EX-32.2 12301
  Complete submission text file 0001297184-19-000027.txt   10931623

Data Files

Seq Description Document Type Size
8 EX-101.INS amph-20190331.xml EX-101.INS 2485716
9 EX-101.SCH amph-20190331.xsd EX-101.SCH 70512
10 EX-101.CAL amph-20190331_cal.xml EX-101.CAL 74297
11 EX-101.DEF amph-20190331_def.xml EX-101.DEF 207150
12 EX-101.LAB amph-20190331_lab.xml EX-101.LAB 492298
13 EX-101.PRE amph-20190331_pre.xml EX-101.PRE 436292
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 19812420
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences